J&J Loses In China’s First Plaintiff-Won Vertical Price Monopoly Lawsuit
This article was originally published in PharmAsia News
Executive Summary
The Shanghai Higher People's Court ruled that defendants Johnson & Johnson Medical (Shanghai) Ltd. and Johnson & Johnson Medical (China) Ltd. must indemnify losses for their 15-year distributor and plaintiff Beijing Firmness Science & Technology Co., Ltd. for RMB 530,000 ($86,470), but not the other earlier-ruled compensation.